FORENAP PHARMA is an International "One-Stop-Shop" CRO specialised in early Drug Development and Research in Neurosciences. Our structure and network enable us to carry out a "full service package" and offer consultancy services from Drug Discovery to Marketing Authorisation. Phase I studies in all therapeutic areas are performed in our 72 highly monitored bed equipped centre. Moreover, FORENAP owns a unique technological platform (wake and sleep-EEG (36 beds), "At your site EEG", MEG, MR, PET scan, Holter ECG...) combined with in-house expertise for investigating Central Nervous System active compounds. In addition FORENAP carries out phase II & III studies mainly in patient suffering from psychiatric and neurodegenerative disorders.
